Cargando…

Structural basis of coreceptor recognition by HIV-1 envelope spike

HIV-1 envelope glycoprotein [Env; trimeric (gp160)(3) cleaved to (gp120/gp41)(3)] interacts with primary receptor CD4 and coreceptor (e.g. chemokine receptor CCR5 or CXCR4) to promote viral entry by fusing viral and target cell membranes. Encounter of gp120 with the coreceptor was thought to be the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaik, Md Munan, Peng, Hanqin, Lu, Jianming, Rits-Volloch, Sophia, Xu, Chen, Liao, Maofu, Chen, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391877/ https://www.ncbi.nlm.nih.gov/pubmed/30542158 http://dx.doi.org/10.1038/s41586-018-0804-9

Ejemplares similares

Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein
por: Piai, Alessandro, et al.
Publicado: (2020)

The Amyloid Cascade Hypothesis 2.0 for Alzheimer’s Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy
por: Volloch, Vladimir, et al.
Publicado: (2023)

Distinct conformational states of SARS-CoV-2 spike protein
por: Cai, Yongfei, et al.
Publicado: (2020)

Structural impact on SARS-CoV-2 spike protein by D614G substitution
por: Zhang, Jun, et al.
Publicado: (2021)

The Amyloid Cascade Hypothesis 2.0: On the Possibility of Once-in-a-Lifetime-Only Treatment for Prevention of Alzheimer’s Disease and for Its Potential Cure at Symptomatic Stages
por: Volloch, Vladimir, et al.
Publicado: (2022)

The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
por: Volloch, Vladimir, et al.
Publicado: (2023)

Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer’s Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions
por: Volloch, Vladimir, et al.
Publicado: (2023)

Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective
por: Volloch, Vladimir, et al.
Publicado: (2023)

Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer’s Disease
por: Volloch, Vladimir, et al.
Publicado: (2018)

Structural and functional impact by SARS-CoV-2 Omicron spike mutations
por: Zhang, Jun, et al.
Publicado: (2022)

Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies
por: Frey, Gary, et al.
Publicado: (2010)

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
por: Cai, Yongfei, et al.
Publicado: (2021)

The Variable Loop 3 in the Envelope Glycoprotein Is Critical for the Atypical Coreceptor Usage of an HIV-1 Strain
por: Xiang, Yue, et al.
Publicado: (2014)

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
por: Wang, Haoqing, et al.
Publicado: (2018)

The Elusive Coreceptors for the SARS-CoV-2 Spike Protein
por: Berkowitz, Reed L., et al.
Publicado: (2022)

Evolution of Multiple Domains of the HIV-1 Envelope Glycoprotein during Coreceptor Switch with CCR5 Antagonist Therapy
por: Du, Yueqi, et al.
Publicado: (2022)

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
por: Xiao, Tianshu, et al.
Publicado: (2021)

V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies
por: Laakso, Meg M, et al.
Publicado: (2007)

Endocytosis and Recycling of the HIV Coreceptor Ccr5
por: Signoret, Nathalie, et al.
Publicado: (2000)

Clinical significance of HIV-1 coreceptor usage
por: Schuitemaker, Hanneke, et al.
Publicado: (2011)

Clipping coreceptors
por: Tuma, Rabiya S.
Publicado: (2005)

Mechanistic basis for the activation of plant membrane receptor kinases by SERK-family coreceptors
por: Hohmann, Ulrich, et al.
Publicado: (2018)

Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART
por: Kitawi, Rose C., et al.
Publicado: (2017)

Antigenic conservation and immunogenicity of the HIV coreceptor binding site
por: Decker, Julie M., et al.
Publicado: (2005)

Coreceptor use in nonhuman primate models of HIV infection
por: Sina, Silvana Tasca, et al.
Publicado: (2011)

Chemokine Coreceptor Signaling in HIV-1 Infection and Pathogenesis
por: Wu, Yuntao, et al.
Publicado: (2009)

HIV coreceptor tropism determination and mutational pattern identification
por: Shen, Hui-Shuang, et al.
Publicado: (2016)

Structure of the Wnt–Frizzled–LRP6 initiation complex reveals the basis for coreceptor discrimination
por: Tsutsumi, Naotaka, et al.
Publicado: (2023)

R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies
por: Loftin, Lamorris M, et al.
Publicado: (2011)

Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor
por: Jacquemard, Célien, et al.
Publicado: (2021)

Understanding the HIV coreceptor switch from a dynamical perspective
por: Kamp, Christel
Publicado: (2009)

HIV Coreceptors and Their Roles in Leukocyte Trafficking During Neuroinflammatory Diseases
por: Klein, Robyn S., et al.
Publicado: (2009)

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)

Correction for Khan et al., “Targeting the HIV-1 Spike and Coreceptor with Bi- and Trispecific Antibodies for Single-Component Broad Inhibition of Entry”
por: Khan, Salar N., et al.
Publicado: (2019)

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120
por: Neurath, A Robert, et al.
Publicado: (2001)

HIV-1 neutralizing antibodies display dual specificity for the primary and coreceptor binding sites and preferential recognition of fully-cleaved Env
por: Li, Y, et al.
Publicado: (2012)

Structural basis of lipopolysaccharide extraction by the LptB(2)FGC complex
por: Li, Yanyan, et al.
Publicado: (2019)

Analysis of Physicochemical and Structural Properties Determining HIV-1 Coreceptor Usage
por: Bozek, Katarzyna, et al.
Publicado: (2013)

Efficient Interaction of HIV-1 with Purified Dendritic Cells via Multiple Chemokine Coreceptors
por: Granelli-Piperno, Angela, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_tgv7vkdflko736on1i1nqmtknm